Reversing the Psychiatric Effects of Neurodevelopmental Cannabinoid Exposure: Exploring Pharmacotherapeutic Interventions for Symptom Improvement
Neurodevelopmental exposure to psychoactive compounds in cannabis, specifically THC, is associated with a variety of long-term psychopathological outcomes. This increased risk includes a higher prevalence of schizophrenia, mood and anxiety disorders, and cognitive impairments. Clinical and pre-clini...
Main Authors: | Marta De Felice, Steven R. Laviolette |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/15/7861 |
Similar Items
-
Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
by: Mina G. Nashed, et al.
Published: (2021-01-01) -
Prenatal cannabinoid exposure and early language development
by: Maria M. Talavera-Barber, et al.
Published: (2023-11-01) -
Cannabinoids, Endocannabinoids and Sleep
by: Andrew J. Kesner, et al.
Published: (2020-07-01) -
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
by: Raquel Maria P. Campos, et al.
Published: (2021-11-01) -
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
by: Jerome Sarris, et al.
Published: (2020-01-01)